What is Elite Pharmaceuticals 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-03), Elite Pharmaceuticals's 12-1 Month Momentum % is 353.33%.
The industry rank for Elite Pharmaceuticals's 12-1 Month Momentum % or its related term are showing as below:
ELTP's 12-1 Month Momentum % is ranked better than 99.55% of 1117
companies
in the Drug Manufacturers industry
Industry Median: -7.37
vs ELTP: 353.33
Competitive Comparison of Elite Pharmaceuticals's 12-1 Month Momentum %
For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Pharmaceuticals's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Elite Pharmaceuticals's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Elite Pharmaceuticals 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Elite Pharmaceuticals's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Elite Pharmaceuticals (Elite Pharmaceuticals) Business Description
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELTP has been successfully added to your